Background The optimal antiplatelet therapy after coronary artery bypass grafting remains
unclear. We evaluated the association of dual antiplatelet therapy (DAPT) with clopidogrel …

OBJECTIVES There is still little evidence to boldport routine dual antiplatelet therapy (DAPT)
with P2Y12 antagonists following coronary artery bypass grafting (CABG). The Arterial …

Background We assessed the effectiveness of dual antiplatelet therapy (DAPT) post elective
or urgent (ie, post acute coronary syndrome [ACS]) coronary artery bypass graft surgery …

Objective: To evaluate the evidence for the use of dual antiplatelet therapy (DAPT) with
aspirin and Clopidogrel following coronary artery bypass graft (CABG) surgery. Data …

Although aspirin monotherapy is considered the standard of care after coronary artery
bypass grafting (CABG), more recent evidence has suggested a benefit with dual antiplatelet …

Background Anti‐platelet therapy is an important component of medical therapy post
coronary artery bypass grafting (CABG). While aspirin administration is a Class I indication …

The impact of dual antiplatelet therapy administration on the risk of bleeding complications
during coronary artery bypass surg Page 1 Creative Commons Attribution-NonCommercial-ShareAlike …

Methods: The search for relevant studies in the present meta-analysis is based on three
approaches: A) systematic searches in electronic databases, B) manual searches in Google …

After acute coronary syndrome (ACS), dual antiplatelet therapy (DAPT) is the standard of
care for both invasive management with percutaneous intervention and noninvasive …

OBJECTIVES There is increasing evidence that dual antiplatelet therapy (DAPT) when
compared with single antiplatelet therapy may improve venous graft patency after coronary …